On April 27, 2018 Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine reported that Mark C. Capone, president and CEO, is scheduled to present at two upcoming investor conferences (Press release, Myriad Genetics, APR 27, 2018, View Source [SID1234525794]). On May 8, 2018, Mr. Capone will present at the 43rd annual Deutsche Bank Healthcare Conference in Boston at 12:50 p.m. ET. On May 16, 2018, Mr. Capone will present at the Bank of America Healthcare Conference in Las Vegas, Nevada at 6:40 p.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentations will be available to interested parties through a live audio webcast accessible through a link in the investor information section of Myriad’s website at www.myriad.com.